The patient Blood Pressure is 140/85 Nad Doc Prescribed Atrovastin 40 and Cinod 10mg Can We Administer Both At a Time
Reading File
Finding Sources
Finding Sources
Searching the Web
atorvastatin 40mg amlodipine 10mg combination drug interaction safety
Reading File
Finding Sources
I now have sufficient information to give a thorough, well-sourced answer.
Can Atorvastatin 40 mg and Amlodipine (Cinod) 10 mg Be Given Together?
Yes, they can be administered together - and this is in fact one of the most common drug combinations in cardiovascular practice. Here is the full clinical picture:
What Are These Drugs?
| Drug | Class | Purpose in This Patient |
|---|---|---|
| Atorvastatin (Atrovastin) 40 mg | HMG-CoA reductase inhibitor (statin) | Lowers LDL cholesterol, cardiovascular risk reduction |
| Amlodipine (Cinod) 10 mg | Dihydropyridine calcium channel blocker | Lowers blood pressure (BP 140/85 warrants treatment) |
Is There a Drug Interaction?
There is a mild pharmacokinetic interaction, but it is not clinically significant at these doses:
- Amlodipine is a weak inhibitor of CYP3A4 - the liver enzyme that metabolizes atorvastatin
- Co-administration increases the AUC (total exposure) of atorvastatin by approximately 18% - the Cmax (peak level) is not meaningfully affected
- The FDA-approved prescribing information for CADUET (the branded fixed-dose combination of amlodipine + atorvastatin) explicitly states this 18% rise is "not clinically meaningful" (Pfizer CADUET label)
Note: This is very different from simvastatin, where amlodipine can double blood levels and the combination carries a real myopathy risk. Atorvastatin is far less sensitive to CYP3A4 inhibition than simvastatin.
Clinical Evidence Supporting Co-Administration
The combination is backed by strong evidence:
- CADUET is an FDA-approved fixed-dose combination pill containing both amlodipine + atorvastatin, studied in over 1,092 patients
- The RESPOND and GEMINI trials showed the combination is well tolerated, with myalgia incidence of only ~1%, similar to either drug alone
- A PMC review found the amlodipine/atorvastatin combination reduced 10-year CHD risk from ~16-18% down to 7-11% in hypertensive patients with dyslipidemia
- The combination may even offer a synergistic benefit - amlodipine + atorvastatin together produce greater reduction in LDL oxidation than either alone
Monitoring Points to Keep in Mind
Even though the combination is safe, counsel the patient to report:
- Muscle pain, weakness, or cramps (myopathy - rare but possible if levels increase)
- Dark-colored urine (sign of rhabdomyolysis - very rare)
- Jaundice or right upper quadrant pain (liver toxicity - rare with atorvastatin)
- Peripheral edema / ankle swelling (common side effect of amlodipine 10 mg)
- Hypotension / dizziness - especially at the 10 mg dose of amlodipine
Food Warning
- Avoid large amounts of grapefruit juice - it inhibits CYP3A4 and can raise atorvastatin levels further
- Avoid heavy alcohol - increases hepatotoxicity risk with atorvastatin
Bottom Line
Administer both safely. This is a well-studied, guideline-supported combination for patients who have both hypertension (BP 140/85 fits Stage 1-2 hypertension) and cardiovascular risk requiring statin therapy. The 18% rise in atorvastatin exposure with amlodipine is not clinically significant at 40 mg. Monitor for muscle symptoms and ankle edema at follow-up.
Sources: Katzung's Basic & Clinical Pharmacology 16th Ed. - CYP3A4 drug interaction table; Pfizer CADUET FDA label (2024); PMC2686256 - RESPOND/GEMINI trial data.
This is a shared conversation. Sign in to Orris to start your own chat.